Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Iruplinalkib |
| Trade Name | |
| Synonyms | WX0593|WX 0593|FL 006|FL-006|FL006|WX-0593 |
| Drug Descriptions |
Iruplinalkib (WX-0593) inhibits ALK and ROS1, with additional activity against EGFR mutations, which may lead to decreased tumor growth (PMID: 35087031; Cancer Res 2018;78(13 Suppl):Abstract nr 4794). |
| DrugClasses | ALK Inhibitor 33 EGFR Inhibitor (Pan) 63 ROS1 Inhibitor 23 |
| CAS Registry Number | 1854943-32-0 |
| NCIT ID | C154279 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Iruplinalkib | Iruplinalkib | 21 | 0 |
| Iruplinalkib + Panitumumab | Iruplinalkib Panitumumab | 0 | 0 |
| Iruplinalkib + QL1203 | Iruplinalkib QL1203 | 0 | 0 |